Toxicology and Pharmacology of CVD

Cardiovascular toxicity encompasses heart damage caused by poison-induced electrophysiological anomalies, muscle damage, and vascular atherosclerosis caused by oxidative stress and inflammation. All of these anomalies may impair blood inflow and movement. The primary bacillus mechanisms underlying cardiovascular toxin may be oxidative stress and inflammation. Cardiovascular toxicology is concerned about the negative effects of extraneous and characteristic weights on the heart and vascular frame. Cardiovascular Pharmacology is the study of the effects of cardiovascular medications on the circulation system or the heart.

  • Dexrazoxane hydrochloride
  • Diuretics
  • ACE inhibitors
  • Beta-blocker

Related Conference of Toxicology and Pharmacology of CVD

May 30-31, 2024

6th Euro Cardiology Congress

Vienna, Austria
May 30-31, 2024

39th World Congress on Heart Diseases

Vienna, Austria
June 20-21, 2024

5th European Summit on Cardiology Research

Dublin, Ireland
July 16-17, 2024

13th World Heart Congress

Paris, France
August 01-02, 2024

38th World Congress on Heart Diseases

Montreal, Canada
September 16-17, 2024

3rd Global Summit on Cardiology and Cardiac Surgery

Paris, France
September 19-20, 2024

7th World Heart and Brain Conference

London, UK
September 19-20, 2024

6th Annual Conference on Vascular Medicine

London, UK
October 17-18, 2024

8th Annual Heart Rhythm Conference

Barcelona, Spain
October 24-25, 2024

11th International Conference on Interventional Cardiology

Zurich, Switzerland

Toxicology and Pharmacology of CVD Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in